Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.34% |
| 2 | Financials | 5.75% |
| 3 | Healthcare | 5.71% |
| 4 | Consumer Discretionary | 5.08% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
RE/MAX Holdings
RMAX
$265M
| $880K | ﹤0.01% |
19,825
+12,822
| +183% | +$638K |
|
3702
CALL
Etsy
ETSY
$7.31B
| $879K | ﹤0.01% |
17,100
-100
| -0.6% | -$4.6K |
|
3703
HealthStream
HSTM
$849M
| $879K | ﹤0.01% |
28,346
+11,762
| +71% | +$352K |
|
3704
Pathward Financial
CASH
$1.78B
| $878K | ﹤0.01% |
31,890
+18,747
| +143% | +$561K |
|
|
FTSI
3705
DELISTED
FTS International, Inc. Common Stock
FTSI
| $877K | ﹤0.01% |
3,715
+2,867
| +338% | +$683K |
|
3706
Gogo Inc
GOGO
$377M
| $876K | ﹤0.01% |
168,893
+58,179
| +53% | +$258K |
|
3707
CALL
Coty
COTY
$2.42B
| $875K | ﹤0.01% |
69,700
+4,800
| +7% | +$62.1K |
|
3708
CALL
Bread Financial
BFH
$4.46B
| $874K | ﹤0.01% |
4,636
-125
| -3% | -$23.6K |
|
3709
ENI
E
$79.1B
| $873K | ﹤0.01% |
23,200
+22,100
| +2,009% | +$833K |
|
3710
Otter Tail
OTTR
$3.87B
| $873K | ﹤0.01% |
18,203
+13,438
| +282% | +$650K |
|
3711
Anika Therapeutics
ANIK
$295M
| $872K | ﹤0.01% |
20,707
+12,008
| +138% | +$474K |
|
3712
Ingles Markets
IMKTA
$1.66B
| $870K | ﹤0.01% |
25,443
+13,264
| +109% | +$433K |
|
3713
PUT
McCormick & Company Non-Voting
MKC
$14.6B
| $870K | ﹤0.01% |
13,200
-23,600
| -64% | -$1.46M |
|
3714
iShares S&P 500 Value ETF
IVE
$50.3B
| $869K | ﹤0.01% |
7,500
-3,411
| -31% | -$391K |
|
|
LDL
3715
DELISTED
Lydall, Inc.
LDL
| $869K | ﹤0.01% |
20,159
+13,836
| +219% | +$597K |
|
3716
ANI Pharmaceuticals
ANIP
$1.72B
| $868K | ﹤0.01% |
15,349
+5,381
| +54% | +$329K |
|
3717
Towne Bank
TOWN
$3.5B
| $868K | ﹤0.01% |
28,170
+23,344
| +484% | +$755K |
|
3718
Rigel Pharmaceuticals
RIGL
$762M
| $866K | ﹤0.01% |
26,956
-31,555
| -54% | -$947K |
|
|
BPL
3719
PUT
DELISTED
Buckeye Partners, L.P.
BPL
| $864K | ﹤0.01% |
24,200
+9,500
| +65% | +$340K |
|
|
HTLF
3720
DELISTED
Heartland Financial USA, Inc.
HTLF
| $863K | ﹤0.01% |
14,872
+11,838
| +390% | +$703K |
|
|
HUD
3721
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $863K | ﹤0.01% |
38,254
+23,707
| +163% | +$460K |
|
3722
Universal Electronics
UEIC
$75.8M
| $861K | ﹤0.01% |
21,859
+12,695
| +139% | +$497K |
|
|
GDEN
3723
DELISTED
Golden Entertainment
GDEN
| $860K | ﹤0.01% |
35,819
+30,817
| +616% | +$864K |
|
3724
American Vanguard Corp
AVD
$64M
| $859K | ﹤0.01% |
47,710
+26,780
| +128% | +$556K |
|
3725
CALL
Genworth Financial
GNW
$3.79B
| $859K | ﹤0.01% |
205,900
-15,200
| -7% | -$68.7K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 7.5% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.